Key Agents and Mechanisms of Action
Key substances with pronounced hallucinogenic activity include lysergic acid diethylamide (LSD), mescaline, and psilocybin. A distinguishing feature of this group is the complete absence of indications for use in official medicine.
Pathological effects on the central nervous system depend directly on the frequency and duration of use:
- A single dose triggers a powerful psychotomimetic effect that frequently escalates into acute psychotic states.
- Repeated use initiates pathophysiological mechanisms of rapid psychological dependence, in which the patient completely loses control over their drug-seeking behavior.
Clinical Presentation of Intoxication
Symptom development can be illustrated by dimescaline—a potent and extremely fast-acting psychoactive compound. The full clinical picture develops within minutes of entering the bloodstream and is traditionally divided into two main categories.
Somatic Manifestations:
- Pronounced tachycardia.
- Arterial hypertension.
- Hyperthermia (significant elevation in core body temperature).
Psychiatric Disorders:
- Rapid, unpredictable mood shifts.
- Total breakdown of reality testing.
- True hallucinations.
- Synesthesia—a pathological blending of senses where stimulation of one sensory modality evokes a response in another (e.g., the ability to "hear" colors).
Hallucinogenic intoxication is associated with life-threatening complications. Patients frequently develop unprovoked panic, exhibit antisocial behaviors (violence, mindless destruction of property), and carry a high risk of suicide.
Polydrug Abuse
Hallucinogens frequently become a component of polydrug abuse (polynarcomania)—a severe condition developing from the simultaneous or alternating use of two or more psychoactive substances. The primary motivation for patients in such cases is the pursuit of a specific complex of rewarding sensations that is fundamentally unachievable with a single drug.
From a pathophysiological standpoint, the key feature of this condition is potentiation—the mutual enhancement of toxic effects among all consumed drugs. This leads to catastrophic consequences for the body:
- Rapid acceleration in the severity of physical dependence.
- Development of an extremely severe and agonizing withdrawal syndrome.
- Profound disruption of homeostasis across all organ systems.
- A sharp decline in the efficacy of any therapeutic interventions.
Dependence on Non-Narcotic Substances
Beyond classic illicit drugs, there are psychoactive substances that may not be legally classified as narcotics, but whose systematic use causes severe pathology. The main categories include:
- Ethanol.
- Psychostimulants (amphetamine, methylphenidate, caffeine).
- Household chemicals (volatile organic solvents, glues, insecticides).
- Psychotropic medications and dissociative anesthetics.
Dissociative Anesthetics
A prominent representative is phencyclidine (a cyclohexylamine derivative), used in veterinary medicine for short-term animal immobilization. In humans, it induces psychomotor agitation, analgesia, dysarthria, and motor coordination deficits. Psychologically, patients exhibit thought disorganization, depersonalization, altered body schema, and severe psychotic states.
Medical Psychotropic Drugs
Legal medications used to treat psychoses, neurotic, and neurosis-like disorders (to alleviate fear, anxiety, and emotional tension) can also induce pathological effects. These include:
- Antipsychotics: chlorpromazine, chlorprothixene, haloperidol.
- Antidepressants: amitriptyline.
- Tranquilizers: medazepam, diazepam, bromdihydrochlorophenylbenzodiazepine.
Their unsupervised use can cause persistent psychological and, with repeated use, physical dependence.